Know What's Happening in Healthcare

Today's Healthcare Pulse

Allogene Therapeutics CEO David Chang to step down

Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.

Blood Factors Drive Aging or Rejuvenation; Therapies Emerging
SocialMay 2, 2026

Blood Factors Drive Aging or Rejuvenation; Therapies Emerging

Aging is increasingly understood as a system-wide process shaped by factors in the blood, which can actively drive either decline or rejuvenation rather than just reflect it. Emerging therapies that modify the circulatory environment show promise in reversing aspects of...

By Liz Parrish
Insurance Denials Mirror Government Budget Cuts in Care
SocialMay 2, 2026

Insurance Denials Mirror Government Budget Cuts in Care

Unfortunately one of the great lies of US HC. Ask anyone with a serious illness that has been denied care by an insurance company that subcontracted out the denial process to a company owned by overseas private equity firms....

By Mark Cuban
Why Artificial Intelligence in Medicine Cannot Replace Clinical Intuition
BlogMay 2, 2026

Why Artificial Intelligence in Medicine Cannot Replace Clinical Intuition

A senior pediatric resident recounts a case where chart data suggested a patient with diabetic ketoacidosis was improving, yet subtle bedside cues indicated a looming cerebral edema. The article argues that artificial‑intelligence tools, trained primarily on electronic health record text,...

By KevinMD
Psychedelics in Medicine: Curiosity & Caution
PodcastMay 2, 20260 min

Psychedelics in Medicine: Curiosity & Caution

In this episode, Dr. Ryan Cole and addiction specialist Dr. Molly Rutherford discuss the surge of interest in psychedelic‑assisted therapies for conditions like addiction, PTSD, and depression, highlighting the recent presidential executive order that accelerates FDA review and funding for these...

By Independent Medical Alliance
New Test Promises to Detect Cancer Earlier, From Tiny Particles in Bodily Fluids
NewsMay 2, 2026

New Test Promises to Detect Cancer Earlier, From Tiny Particles in Bodily Fluids

Researchers at the University of Calgary have unveiled EXOSense, a patent‑pending platform that electrically isolates small extracellular vesicles from blood or urine for cancer screening. These vesicles carry molecular signatures that appear long before conventional biomarkers, offering a potential route...

By Medical Xpress
FDA Approves First‑In‑Human Trial of Motif Neurotech’s Depression Brain Implant
NewsMay 2, 2026

FDA Approves First‑In‑Human Trial of Motif Neurotech’s Depression Brain Implant

The U.S. Food and Drug Administration has granted Motif Neurotech permission to begin a first‑in‑human study of its miniature brain‑computer interface designed for treatment‑resistant depression. The Houston‑based startup says the device, the size of a blueberry, can be implanted in...

By Pulse
Meta‑Analysis Shows GLP‑1 Drugs Cut Cardiovascular Events by 13% Over Three Years
NewsMay 2, 2026

Meta‑Analysis Shows GLP‑1 Drugs Cut Cardiovascular Events by 13% Over Three Years

Researchers at Anglia Ruskin University analyzed data from more than 90,000 patients and found GLP‑1 receptor agonists lower major adverse cardiovascular events by roughly 13% over an average three‑year follow‑up. The benefit appears across diabetic and non‑diabetic high‑risk groups, reinforcing...

By Pulse
FDA ODAC Backs AstraZeneca’s Truqap Combo for PTEN‑deficient Prostate Cancer
NewsMay 2, 2026

FDA ODAC Backs AstraZeneca’s Truqap Combo for PTEN‑deficient Prostate Cancer

The FDA’s Oncologic Drugs Advisory Committee voted 7‑1 to recommend AstraZeneca’s Truqap (capivasertib) combined with abiraterone and androgen deprivation therapy for PTEN‑deficient metastatic hormone‑sensitive prostate cancer. The recommendation follows the CAPItello‑281 Phase III trial, which showed a 19% reduction in radiographic...

By Pulse
Spring Health Acquires Alma to Build Lifelong Mental‑Health Platform
NewsMay 2, 2026

Spring Health Acquires Alma to Build Lifelong Mental‑Health Platform

Spring Health announced the closing of its acquisition of Alma, merging two AI‑native mental‑health providers into a single platform that now supports more than 170 million lives worldwide. The deal, finalized after regulatory clearance, aims to eliminate care fragmentation and deliver...

By Pulse
Telehealth and Mail‑order Meds Sustain Abortion Access Post‑Roe
SocialMay 2, 2026

Telehealth and Mail‑order Meds Sustain Abortion Access Post‑Roe

Telehealth and abortion medication delivered by mail have been instrumental in helping to preserve access following the Supreme Court’s decision overturning the right to an abortion. https://www.kff.org/womens-health-policy/key-facts-on-abortion-in-the-united-states/

By Larry Levitt
Cleveland Clinic Launches AI‑Powered Overhaul of Referral Operations with Luminai
NewsMay 2, 2026

Cleveland Clinic Launches AI‑Powered Overhaul of Referral Operations with Luminai

Cleveland Clinic has begun a system‑wide AI transformation, teaming with startup Luminai to automate referral management and other back‑office workflows. The pilot that once handled millions of faxes is moving toward broader deployment across the health system’s 23 hospitals and...

By Pulse
FDA Grants Expanded Access to Revolution Medicines' Pancreatic Cancer Pill Daraxonrasib
NewsMay 2, 2026

FDA Grants Expanded Access to Revolution Medicines' Pancreatic Cancer Pill Daraxonrasib

The U.S. Food and Drug Administration approved an expanded‑access program for Revolution Medicines' experimental pancreatic cancer drug daraxonrasib, allowing eligible patients to receive the pill before formal approval. The move follows trial data that doubled median survival versus chemotherapy and...

By Pulse
BREAKING: 146 NEUROLOGICAL AND PSYCHIATRIC CDC/FDA SAFETY SIGNALS WERE BREACHED WITH COVID SHOTS
BlogMay 2, 2026

BREAKING: 146 NEUROLOGICAL AND PSYCHIATRIC CDC/FDA SAFETY SIGNALS WERE BREACHED WITH COVID SHOTS

A recent Substack post by Nicolas Hulscher alleges that COVID‑19 mRNA vaccines breached 146 CDC/FDA safety signals, citing astronomical relative‑risk figures such as a 3,000‑fold increase in brain clots and a 7.4% national rate of cognitive disability. The author claims...

By Exposing The Darkness
Assessing the Usefulness, Availability and Maintenance of Automated External Defibrillators in Emergency Care in Greater Accra
NewsMay 2, 2026

Assessing the Usefulness, Availability and Maintenance of Automated External Defibrillators in Emergency Care in Greater Accra

A recent cross‑sectional study of Ghana's National Ambulance Service in Greater Accra found that, while staff widely recognize the life‑saving value of automated external defibrillators (AEDs), only about two‑thirds of ambulance stations had a functional unit. Common problems included expired...

By Research Square – News/Updates
The Evolving Structural Challenges of Modern Pain Medicine
BlogMay 2, 2026

The Evolving Structural Challenges of Modern Pain Medicine

Interventional pain medicine has expanded dramatically, adding complex device‑based therapies such as spinal cord stimulation, dorsal root ganglion stimulation, and minimally invasive decompression. Simultaneously, training pathways, reimbursement models, and research infrastructure have lagged, creating variability in procedural exposure and declining...

By KevinMD
Development Analysis and Strategic Insights From a 505(b)(2) Reformulation Product: Enzalutamide
NewsMay 2, 2026

Development Analysis and Strategic Insights From a 505(b)(2) Reformulation Product: Enzalutamide

Astellas used the 505(b)(2) pathway to reformulate enzalutamide (XTANDI®) from a 40 mg lipid‑filled soft capsule into 40 mg and 80 mg film‑coated tablets, aiming to cut pill burden. Five biopharmaceutic studies demonstrated comparable AUC between the two dosage forms, while the tablet...

By Research Square – News/Updates
Mortality Risk Doubled in Alcohol-Related Vs. MASH Cirrhosis
NewsMay 2, 2026

Mortality Risk Doubled in Alcohol-Related Vs. MASH Cirrhosis

A propensity‑matched analysis of 31,090 patients per group found that alcohol‑related cirrhosis carries more than twice the mortality risk of metabolic dysfunction‑associated steatohepatitis (MASH) cirrhosis, despite comparable liver‑severity markers. The study also identified a 55% higher incidence of portal vein...

By Healio
APT and GluCEST Imaging at 5.0 T in Patients with Brain Tumors: A Phantom Reproducibility Validation and Clinical Study
NewsMay 2, 2026

APT and GluCEST Imaging at 5.0 T in Patients with Brain Tumors: A Phantom Reproducibility Validation and Clinical Study

Researchers evaluated the reproducibility of amide proton transfer (APT) and glutamate chemical exchange saturation transfer (GluCEST) MRI at 5 Tesla using phantom experiments and a cohort of 96 brain‑tumor patients. Phantom tests showed intraclass correlation coefficients above 0.96 and coefficients of...

By Research Square – News/Updates
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
BlogMay 2, 2026

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue

Edwards Lifesciences released 10‑year results from the COMMENCE aortic trial, confirming that its RESILIA tissue surgical valves retain high durability. At ten years, 97.9% of patients were free from structural valve deterioration and 97.8% avoided reoperation. The data also show...

By HealthTech HotSpot
Effect of Virtual Reality on Acute Stress Response and Discomfort During Vacuum-Assisted Closure (VAC) Dressing Changes: A Protocol for Randomized...
NewsMay 2, 2026

Effect of Virtual Reality on Acute Stress Response and Discomfort During Vacuum-Assisted Closure (VAC) Dressing Changes: A Protocol for Randomized...

A randomized controlled trial will evaluate immersive virtual reality (VR) as a non‑pharmacologic method to lessen acute stress during vacuum‑assisted closure (VAC) dressing changes. Participants are split 1:1 between VR and standard care, with primary endpoints including heart rate, blood...

By Research Square – News/Updates
Hawke’s Bay’s New $25 Million Hospice Granted Consent in Hastings
NewsMay 2, 2026

Hawke’s Bay’s New $25 Million Hospice Granted Consent in Hastings

Cranford Hospice in Hawke’s Bay secured resource consent to build a new $25.5 million facility (≈$15.3 million USD) on a 1.1‑hectare site at 238 Havelock Rd. To date, donors have contributed about $19.5 million (≈$11.7 million USD), covering most of the projected cost. Construction...

By NZ Herald – Business
Robotic-Assisted Surgery Introduced in Hawke’s Bay with Royston Hospital Urology Operations
NewsMay 2, 2026

Robotic-Assisted Surgery Introduced in Hawke’s Bay with Royston Hospital Urology Operations

Robotic‑assisted surgery arrived in Hawke’s Bay as Royston Hospital installed Medtronic’s Hugo system, marking the region’s first use of a surgical robot. The first two procedures, robot‑assisted prostatectomies, were completed in March 2024, allowing patients to stay local instead of...

By NZ Herald – Business
Diets, Frequent Sex Offer No Protection Against Prostate Cancer, Surgeon Warns Nigerians
NewsMay 2, 2026

Diets, Frequent Sex Offer No Protection Against Prostate Cancer, Surgeon Warns Nigerians

At the one‑year anniversary of The Prostate Clinic in Lagos, consultant urological surgeon Kingsley Ekwueme warned that neither diet nor frequency of sexual activity prevents prostate cancer. He highlighted that misinformation on social media leads many Nigerian men to rely...

By BusinessDay (Nigeria)
‘Deeply Concerning’ Disparities in Alcohol-Associated Hepatitis Worsened During Pandemic
NewsMay 2, 2026

‘Deeply Concerning’ Disparities in Alcohol-Associated Hepatitis Worsened During Pandemic

A retrospective cohort study of 907,390 U.S. hospitalizations for alcohol‑associated hepatitis (2016‑2022) found mortality rose from 3.9% pre‑pandemic to 4.6% during and after COVID‑19. The increase was driven by disproportionate spikes among Native American (6.3% mortality) and Hispanic patients (4.3%)....

By Healio
Balancing Reform and Regulation in Mental Health Care
SocialMay 2, 2026

Balancing Reform and Regulation in Mental Health Care

Here's a weird tension we don't yet have a clear path to navigate in the mental health system. - Many mental health systems we have in place have been and continue to be oppressive, carceral, and coercive, particularly to marginalized folks. and -...

By Dr. Jessica Goodnight
Denied Drug Everolimus Available for $30.88
SocialMay 2, 2026

Denied Drug Everolimus Available for $30.88

Wanna know how fucked up this is ? The drug that was denied , Everolimus , can be as low as $30.88 on @costplusdrugs

By Mark Cuban
Beyond Not Controlling the Narrative, It's About Being Human
NewsMay 2, 2026

Beyond Not Controlling the Narrative, It's About Being Human

In a recent BMJ rapid response, resident doctor Eve Ducker expands on John Launer’s warning against doctors “controlling the narrative.” She argues that the core issue is the loss of humanity in consultations, where clinicians often speak first and listen later....

By BMJ (Latest)
Longevity Pill May Redefine Human‑dog Bonds
SocialMay 2, 2026

Longevity Pill May Redefine Human‑dog Bonds

YOUR NEXT DOG A new pill could soon extend dogs’ lives. How will that change our relationship with our pets? By @andersen 🔗https://t.co/u2cuBfKGuU https://t.co/Iaw4uoZfZe

By David Barzilai, MD PhD
Spice Cabinet May Hold Next Diabetes Treatment
SocialMay 2, 2026

Spice Cabinet May Hold Next Diabetes Treatment

Could a new tool for diabetes treatment be hiding in your spice cabinet? https://t.co/L5RWYeEY9q https://t.co/U4Boj4W4EQ

By David Barzilai, MD PhD
National Hospital Week Reveals What Care Really Takes
BlogMay 2, 2026

National Hospital Week Reveals What Care Really Takes

National Hospital Week, observed May 10‑16, highlights the intricate coordination that powers U.S. hospitals. The American Hospital Association reports hospitals employ more than 6.6 million people and purchase over $1.3 trillion in goods and services, driving $4.8 trillion in economic activity. The piece emphasizes...

By KevinMD
Zuckerberg Funds $500M AI to Model Human Cells
SocialMay 2, 2026

Zuckerberg Funds $500M AI to Model Human Cells

Mark Zuckerberg backs $500 million push to build AI models of human cells as part of long-term effort to cure disease. https://t.co/nLBDaUVj9Z

By TechRadar
Patent Monopolies Fueled Opioid Crisis, Perdue Falls
SocialMay 2, 2026

Patent Monopolies Fueled Opioid Crisis, Perdue Falls

With Perdue Pharma biting the dust, it might be a good time for a post-mortem that looks at the government-granted patent monopolies that provided the incentive for pushing opioids https://t.co/bWKnxlYaS2

By Dean Baker
Retina Scan for Diabetes Could Also Reduce Deaths During Pregnancy in Developing Countries
NewsMay 2, 2026

Retina Scan for Diabetes Could Also Reduce Deaths During Pregnancy in Developing Countries

Bill Gates highlighted Remidio's AI‑powered retinal camera that captures high‑resolution eye images in seconds using a smartphone. The device, already deployed in 40 countries for over 15 million diabetes screenings, can also identify early signs of gestational diabetes and pre‑eclampsia without...

By Slashdot
Melatonin Shields Mitochondria From Radiation Damage
SocialMay 2, 2026

Melatonin Shields Mitochondria From Radiation Damage

Melatonin as a radioprotectant against mitochondrial damage 🤔"Melatonin can protect against irradiation-induced mitochondrial damage, suggesting utility for mitigating the health effects of accidental radiation exposure." https://t.co/XHZYDE916a

By David Barzilai, MD PhD
Malaria Vaccine Team Faced Funding Delays at Every Stage
SocialMay 2, 2026

Malaria Vaccine Team Faced Funding Delays at Every Stage

“The researchers who worked on this malaria vaccine struggled at every step of the process to get faster funding.” ~@salonium

By Jim O’Shaughnessy
Obesity as a Neurobiological Disease: Fatima Cody Stanford, MD, MPH
NewsMay 2, 2026

Obesity as a Neurobiological Disease: Fatima Cody Stanford, MD, MPH

In a May 2, 2026 interview with AJMC, Harvard‑affiliated physician Fatima Cody Stanford explains that obesity is rooted in neurobiological pathways, chiefly the anorexigenic POMC and orexigenic AgRP circuits. She highlights how GLP‑1 receptor agonists and dual GIP/GLP‑1 agents modulate these pathways to promote...

By AJMC (The American Journal of Managed Care)
Re: Why Doesn’t the NHS Know Where Its Medicines Are?
NewsMay 2, 2026

Re: Why Doesn’t the NHS Know Where Its Medicines Are?

Retired nurse practitioner Brian J. Collis wrote to the BMJ describing a personal experience with a Trurapi insulin shortage in the NHS. His local pharmacy could not source the product, forcing him to call NHS 111 for an emergency prescription...

By BMJ (Latest)
Pune Rolls Out 15 New Mental Health Centers and Tech‑Driven Wellness Campaign
NewsMay 2, 2026

Pune Rolls Out 15 New Mental Health Centers and Tech‑Driven Wellness Campaign

Pune municipal authorities and the Maharashtra state government announced the opening of 15 new community mental health centers and an upgraded 24/7 tele‑mental health helpline, while launching a citywide fitness and preventive‑care campaign. The integrated effort combines free counseling, multilingual...

By Pulse
Study Links Troponin‑I Phosphorylation in Obesity to Heart Failure, Reversible with Weight Loss
NewsMay 2, 2026

Study Links Troponin‑I Phosphorylation in Obesity to Heart Failure, Reversible with Weight Loss

A new study published in Science identified heightened phosphorylation of the protein troponin‑I as a molecular switch that weakens heart muscle in people with severe obesity and HFpEF. Patients who lost more than 2 kg/m² BMI using GLP‑1 agonists showed restored...

By Pulse
Semaglutide Cuts Heavy Alcohol Drinking in Obese Patients, Lancet Trial Shows
NewsMay 2, 2026

Semaglutide Cuts Heavy Alcohol Drinking in Obese Patients, Lancet Trial Shows

A randomized, double‑blind trial led by Copenhagen University Hospital shows semaglutide, the GLP‑1 agonist behind Wegovy and Ozempic, significantly reduces heavy drinking episodes in patients with obesity and alcohol use disorder. The findings, published in The Lancet, could expand treatment...

By Pulse
FDA, AstraZeneca and Amgen Launch Real‑Time Clinical Trials Initiative
NewsMay 2, 2026

FDA, AstraZeneca and Amgen Launch Real‑Time Clinical Trials Initiative

The U.S. Food and Drug Administration announced a real‑time clinical trials (RTCT) program backed by AstraZeneca and Amgen, allowing safety and efficacy data to flow continuously to regulators. The pilot seeks to trim the 10‑12‑year development cycle by eliminating the...

By Pulse
Smile Makers Debuts $69 Pelvic‑Floor Wearable, Aiming to Democratize At‑Home Women’s Health
NewsMay 2, 2026

Smile Makers Debuts $69 Pelvic‑Floor Wearable, Aiming to Democratize At‑Home Women’s Health

Smile Makers launched the Pelvic Partner, a $69 wearable that provides real‑time biofeedback for pelvic‑floor training. The device targets women seeking a low‑cost, at‑home alternative to clinical therapy, reflecting growing consumer demand for discreet, preventive health tech.

By Pulse
CMS Medicare Portal Leak Exposes Dozens of Provider SSNs, Sparks Congressional Probe
NewsMay 2, 2026

CMS Medicare Portal Leak Exposes Dozens of Provider SSNs, Sparks Congressional Probe

The Centers for Medicare & Medicaid Services (CMS) disclosed that a publicly accessible Medicare directory inadvertently revealed the Social Security numbers of dozens of health‑care providers. The breach, traced to providers entering data in the wrong fields, has triggered swift...

By Pulse
Oura Adds Birth‑Control and Menopause Tracking to Smart Ring
NewsMay 2, 2026

Oura Adds Birth‑Control and Menopause Tracking to Smart Ring

Oura is launching Hormonal Birth Control support and Menopause Insights on its smart ring, beginning May 6. The update lets users log over 20 contraception methods and track menopause symptoms, linking them to temperature, sleep and recovery data.

By Pulse
Nebraska Launches Medicaid Work Requirements, Threatening Coverage for Up to 25,000 Residents
NewsMay 2, 2026

Nebraska Launches Medicaid Work Requirements, Threatening Coverage for Up to 25,000 Residents

Nebraska on May 1 became the first U.S. state to enforce the federal Medicaid work‑requirement provision, affecting roughly 70,000 expansion enrollees. Analysts estimate as many as 25,000 Nebraskans could lose coverage, igniting a clash between state officials touting workforce incentives...

By Pulse
MHRA Names Former CDC CIO Jason Bonander as New Chief Digital and Technology Officer
NewsMay 2, 2026

MHRA Names Former CDC CIO Jason Bonander as New Chief Digital and Technology Officer

The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed Jason Bonander, former CIO of the U.S. CDC, as its chief digital and technology officer. He will steer a five‑year modernization plan that emphasizes data, AI oversight and agile regulation,...

By Pulse
Georgia Woman Sues over Da Vinci Robot Hysterectomy Complications, Sparking Safety Debate
NewsMay 2, 2026

Georgia Woman Sues over Da Vinci Robot Hysterectomy Complications, Sparking Safety Debate

Star Button, a 38‑year‑old Atlanta resident, has filed a negligence suit against Southern Regional Medical Center and the late Dr. Beverly Love, alleging that a Da Vinci robot‑assisted hysterectomy left her with massive blood loss, infections and permanent disability. The...

By Pulse
Incyte Secures FDA Nod for Jakafi XR Extended‑Release Tablets Across Three Hematologic Indications
NewsMay 2, 2026

Incyte Secures FDA Nod for Jakafi XR Extended‑Release Tablets Across Three Hematologic Indications

Incyte announced that the FDA approved Jakafi XR (ruxolitinib) extended‑release tablets for adults with intermediate‑ or high‑risk myelofibrosis, polycythemia vera refractory to hydroxyurea, and adults and children 12 + with steroid‑refractory acute or chronic graft‑versus‑host disease. The once‑daily formulation is bioequivalent...

By Pulse
Combining Alcohol with Cocaine Rewires the Brain’s Relapse Pathways Differently than Cocaine Alone
NewsMay 2, 2026

Combining Alcohol with Cocaine Rewires the Brain’s Relapse Pathways Differently than Cocaine Alone

A study in Neuropsychopharmacology shows that combining alcohol with cocaine rewires the brain circuits that drive relapse. In rats, chemogenetic inhibition of the prelimbic cortex‑to‑nucleus accumbens core pathway stopped cocaine‑only seeking but failed when the animals also consumed alcohol. The...

By PsyPost